House Bill 1463 establishes the Task Force on Diabetes Management within the Department of Health to evaluate the need for a referral program directing individuals diagnosed with diabetes to federally qualified health centers, regardless of their health coverage status. The task force will develop criteria for these referrals and is required to submit a report to the Governor and Legislature by May 1, 2026. It will consist of appointed members with expertise in health care, insurance, and public health, and will dissolve upon the submission of its report, although the State Surgeon General can reestablish it if necessary.

The bill also amends existing laws to enhance coverage for diabetes-related drugs and devices under health insurance policies in Florida. It introduces definitions for various diabetes-related terms and mandates that health insurance policies cover laboratory and diagnostic testing for diabetes without certain cost-sharing requirements. Additionally, it caps out-of-pocket expenses for insulin and diabetes devices, ensuring patients are charged no more than $35 for a 30-day supply of insulin and $100 for other necessary diabetes-related devices. The bill further requires health maintenance contracts to provide similar coverage and revises the prescription drug monitoring program to include reporting for diabetes-related medications and devices. The provisions are set to take effect on July 1, 2025.